SEC Filings | Zentalis Pharmaceuticals

Filing Date	Form	Description	View
Jun 15, 2023	8-K	Report of unscheduled material events or corporate event	0001628280-23-022240.pdf 0001628280-23-022240.rtf 0001628280-23-022240.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jun 06, 2023	8-K	Report of unscheduled material events or corporate event	0001725160-23-000131.pdf 0001725160-23-000131.rtf 0001725160-23-000131.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jun 05, 2023	8-K	Report of unscheduled material events or corporate event	0001725160-23-000129.pdf 0001725160-23-000129.rtf 0001725160-23-000129.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 31, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001950047-23-001083.pdf 0001950047-23-001083.rtf View HTML
May 31, 2023	4	Statement of changes in beneficial ownership of securities	0001725160-23-000125.pdf 0001725160-23-000125.rtf 0001725160-23-000125.xls View HTML
May 31, 2023	4	Statement of changes in beneficial ownership of securities	0001725160-23-000124.pdf 0001725160-23-000124.rtf 0001725160-23-000124.xls View HTML
May 31, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001725160-23-000126.pdf 0001725160-23-000126.rtf View HTML
May 26, 2023	8-K	Report of unscheduled material events or corporate event	0001725160-23-000119.pdf 0001725160-23-000119.rtf 0001725160-23-000119.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 10, 2023	8-K	Report of unscheduled material events or corporate event	0001725160-23-000112.pdf 0001725160-23-000112.rtf 0001725160-23-000112.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 10, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001725160-23-000114.pdf 0001725160-23-000114.rtf 0001725160-23-000114.xls View HTML

Data provided by Kaleidoscope.